X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (709) 709
index medicus (686) 686
animals (397) 397
female (281) 281
male (263) 263
oncology (168) 168
mice (158) 158
cancer (149) 149
middle aged (145) 145
pharmacology & pharmacy (145) 145
cell biology (136) 136
biochemistry & molecular biology (133) 133
adult (123) 123
research (118) 118
proteins (114) 114
health aspects (112) 112
apoptosis (110) 110
analysis (108) 108
aged (102) 102
care and treatment (96) 96
article (94) 94
inflammation (89) 89
cell line, tumor (82) 82
gene expression (78) 78
rats (78) 78
expression (76) 76
immunology (75) 75
gastroenterology & hepatology (74) 74
physiological aspects (74) 74
genetic aspects (73) 73
signal transduction (72) 72
medicine (71) 71
treatment outcome (69) 69
in-vitro (64) 64
neurosciences (63) 63
risk factors (63) 63
medicine, research & experimental (62) 62
research article (62) 62
review (62) 62
activation (59) 59
helicobacter pylori (59) 59
nlr family, pyrin domain-containing 3 protein (58) 58
nitrogen-containing bisphosphonates (57) 57
amine oxidase (55) 55
medicine & public health (55) 55
rodents (54) 54
tumors (53) 53
oxidative stress (52) 52
multidisciplinary sciences (51) 51
biology (50) 50
development and progression (50) 50
disease (50) 50
helicobacter infections - drug therapy (48) 48
chemotherapy (47) 47
disease models, animal (47) 47
inflammasomes - metabolism (47) 47
apoptosis - drug effects (46) 46
nf-kappa-b (46) 46
prognosis (45) 45
drug therapy, combination (44) 44
mutation (44) 44
studies (44) 44
enzymes (43) 43
hematology (43) 43
endocrinology & metabolism (42) 42
in-vivo (42) 42
inhibition (42) 42
microbiology (42) 42
phosphorylation (42) 42
cell line (41) 41
cells, cultured (41) 41
breast cancer (40) 40
cells (40) 40
kinases (40) 40
therapy (40) 40
metabolism (39) 39
mice, inbred c57bl (39) 39
gene-expression (38) 38
jumonji domain-containing histone demethylases - metabolism (38) 38
adolescent (35) 35
aged, 80 and over (35) 35
anti-bacterial agents - therapeutic use (35) 35
antibiotic-resistance (35) 35
brain (35) 35
cytokines (35) 35
drug therapy (35) 35
infection (35) 35
sequential therapy (35) 35
zoledronic acid (35) 35
metastasis (34) 34
patients (34) 34
medical research (33) 33
nlr family, pyrin domain-containing 3 protein - metabolism (33) 33
antineoplastic agents - pharmacology (32) 32
carrier proteins - metabolism (32) 32
genes (32) 32
cell cycle (31) 31
containing quadruple therapy (30) 30
double-blind (30) 30
gene expression regulation, neoplastic (30) 30
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2014, Volume 12, Issue 2, pp. 177 - 186.e3
Data are available such that choice of Helicobacter pylori therapy for an individual patient can be reliably predicted. Here, treatment success is defined as a... 
Gastroenterology and Hepatology | Clarithromycin | Proton Pump Inhibitors | Review | Tetracycline | Treatment | Helicobacter pylori | Concomitant Therapy | Treatment Success | Amoxicillin | Quadruple Therapy | Bismuth | Metronidazole | Sequential Therapy | Evidence Based | Treatment success | Sequential therapy | Proton pump inhibitors | Concomitant therapy | Evidence based | Quadruple therapy | Therapy | PROTON-PUMP INHIBITOR | Sequential | CAGA STATUS | TRIPLE THERAPY | INFECTION | ANTIBIOTIC-RESISTANCE | RANDOMIZED-TRIAL | CONTAINING CONCOMITANT THERAPY | SEQUENTIAL THERAPY | ERADICATION THERAPY | GASTROENTEROLOGY & HEPATOLOGY | Bismuth - administration & dosage | Helicobacter Infections - drug therapy | Humans | Metronidazole - administration & dosage | Treatment Failure | Clarithromycin - administration & dosage | Drug Resistance, Bacterial | Amoxicillin - administration & dosage | Drug Therapy, Combination | Evidence-Based Medicine | Anti-Bacterial Agents - administration & dosage | Urea | Medical colleges | Continuing medical education | Gastrointestinal diseases | Helicobacter infections | Evidence-based medicine | Antibacterial agents | treatment | concomitant therapy | amoxicillin | treatment success | clarithromycin | sequential therapy | proton pump inhibitors | review | tetracycline | metronidazole | quadruple therapy | evidence based | bismuth
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 151, Issue 1, pp. 51 - 69.e14
Background & Aims Helicobacter pylori infection is increasingly difficult to treat. The purpose of these consensus statements is to provide a review of the... 
Gastroenterology and Hepatology | Resistance | Rifabutin | Levofloxacin | Clarithromycin | Helicobacter pylori | Proton Pump Inhibitor | Amoxicillin | Bismuth | Metronidazole | Eradication | Tetracycline | CONTAINING QUADRUPLE THERAPY | CONTAINING TRIPLE-THERAPY | CONCOMITANT THERAPY | ANTIBIOTIC-RESISTANCE | SEQUENTIAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | CLINICAL-PRACTICE GUIDELINES | STANDARD TRIPLE | LEVOFLOXACIN-CONTAINING TRIPLE | GASTROENTEROLOGY & HEPATOLOGY | Bismuth - standards | Bismuth - administration & dosage | Drug Administration Schedule | Humans | Metronidazole - administration & dosage | Clarithromycin - standards | Proton Pump Inhibitors - standards | Amoxicillin - standards | Anti-Infective Agents - standards | Metronidazole - standards | Canada | Anti-Infective Agents - administration & dosage | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Levofloxacin - standards | Clarithromycin - administration & dosage | Adult | Amoxicillin - administration & dosage | Tetracycline - standards | Tetracycline - administration & dosage | Drug Therapy, Combination - standards | Levofloxacin - administration & dosage | Care and treatment | Continuing medical education | Surgical clinics | Children's hospitals | Helicobacter infections | Adults | Epidemiology | Antiulcer drugs
Journal Article
Journal Article
Journal Article
GASTROENTEROLOGIA Y HEPATOLOGIA, ISSN 0210-5705, 12/2016, Volume 39, Issue 10, pp. 697 - 721
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus... 
CONTAINING QUADRUPLE THERAPY | Clarithromycin | CONCOMITANT THERAPY | Proton pump | DUODENAL-ULCER | PROTON-PUMP INHIBITOR | BLEEDING PEPTIC-ULCER | SEQUENTIAL THERAPY | Omeprazole | STANDARD TRIPLE THERAPY | Helicobacter pylori | inhibitor | Bismuth | ERADICATION THERAPY | Metronidazole | GASTROENTEROLOGY & HEPATOLOGY | 3RD-LINE RESCUE THERAPY | MAASTRICHT-III CONSENSUS
Journal Article
Journal Article